Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study

Overview of attention for article published in BMC Gastroenterology, November 2014

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

New Reflux Medication by AstraZeneca given a thumbs up in trial http://www.biomedcentral.com/1471-230X/14/188/abstract

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.